Cover Image
Market Research Report
Product code
1031931

Healthcare Contract Development & Manufacturing Organization Market Research Report by Services, by End-User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

Published: | 360iResearch LLP | 187 Pages | Delivery time: 1-2 business days

Price

Back to Top
Healthcare Contract Development & Manufacturing Organization Market Research Report by Services, by End-User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
Published: October 10, 2021
360iResearch LLP
Content info: 187 Pages
Delivery time: 1-2 business days
  • ALL
  • Description
  • Table of Contents
Description

The Global Healthcare Contract Development & Manufacturing Organization Market size was estimated at USD 219.63 billion in 2020 and expected to reach USD 247.78 billion in 2021, at a CAGR 13.15% to reach USD 461.12 billion by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Healthcare Contract Development & Manufacturing Organization to forecast the revenues and analyze the trends in each of the following sub-markets:

  • Based on Services, the market was studied across Clinical, Contract Development, Contract Manufacturing, and Laboratory Services. The Clinical is further studied across Phase I, Phase II, Phase III, and Phase IV. The Contract Development is further studied across Preclinical. The Preclinical is further studied across Bioanalysis and DMPK studies and Toxicology Testing. The Contract Manufacturing is further studied across API/Bulk Drugs, Finished Dose Formulations, and Medical Device. The Medical Device is further studied across Class I, Class II, and Class III. The Laboratory Services is further studied across Analytical Services and Bioanalytical Services.
  • Based on End-User, the market was studied across Big Pharmaceutical Companies, Generic Pharmaceutical Companies, and Small & Medium-Sized Pharmaceutical Companies.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Healthcare Contract Development & Manufacturing Organization Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Healthcare Contract Development & Manufacturing Organization Market, including Catalent Inc., Covance Inc., Flex, IQVIA Holdings Inc., Jabil, Lonza Group Ltd., Recipharm AB, Sanmina Corporation, Siegfried Holding AG, and Thermo Fisher Scientific Inc..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Healthcare Contract Development & Manufacturing Organization Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Healthcare Contract Development & Manufacturing Organization Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Healthcare Contract Development & Manufacturing Organization Market?
  • 4. What is the competitive strategic window for opportunities in the Global Healthcare Contract Development & Manufacturing Organization Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Healthcare Contract Development & Manufacturing Organization Market?
  • 6. What is the market share of the leading vendors in the Global Healthcare Contract Development & Manufacturing Organization Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Healthcare Contract Development & Manufacturing Organization Market?
Table of Contents
Product Code: MRR-B812DD5799FC

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Define: Research Objective
  • 2.3. Determine: Research Design
  • 2.4. Prepare: Research Instrument
  • 2.5. Collect: Data Source
  • 2.6. Analyze: Data Interpretation
  • 2.7. Formulate: Data Verification
  • 2.8. Publish: Research Report
  • 2.9. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction

4. Market Overview

  • 4.1. Introduction
  • 4.2. Cumulative Impact of COVID-19

5. Market Dynamics

  • 5.1. Introduction
  • 5.2. Drivers
    • 5.2.1. Increasing outsourcing services by pharmaceutical companies
    • 5.2.2. Patent expiry and increasing demand for generic drugs
    • 5.2.3. Increasing demand for one-stop-shop contract development & manufacturing organization
  • 5.3. Restraints
    • 5.3.1. Compliance issues while outsourcing and regulatory and legal compliance
  • 5.4. Opportunities
    • 5.4.1. Increasing investment in pharmaceutical research & development
    • 5.4.2. Increasing demand for biological therapies
  • 5.5. Challenges
    • 5.5.1. Capacity utilization issues affecting the profitability of contract development & manufacturing organization

6. Healthcare Contract Development & Manufacturing Organization Market, by Services

  • 6.1. Introduction
  • 6.2. Clinical
    • 6.2.1. Phase I
    • 6.2.2. Phase II
    • 6.2.3. Phase III
    • 6.2.4. Phase IV
  • 6.3. Contract Development
    • 6.3.1. Preclinical
      • 6.3.1.1. Bioanalysis and DMPK studies
      • 6.3.1.2. Toxicology Testing
  • 6.4. Contract Manufacturing
    • 6.4.1. API/Bulk Drugs
    • 6.4.2. Finished Dose Formulations
    • 6.4.3. Medical Device
      • 6.4.3.1. Class I
      • 6.4.3.2. Class II
      • 6.4.3.3. Class III
  • 6.5. Laboratory Services
    • 6.5.1. Analytical Services
    • 6.5.2. Bioanalytical Services

7. Healthcare Contract Development & Manufacturing Organization Market, by End-User

  • 7.1. Introduction
  • 7.2. Big Pharmaceutical Companies
  • 7.3. Generic Pharmaceutical Companies
  • 7.4. Small & Medium-Sized Pharmaceutical Companies

8. Americas Healthcare Contract Development & Manufacturing Organization Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Healthcare Contract Development & Manufacturing Organization Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand

10. Europe, Middle East & Africa Healthcare Contract Development & Manufacturing Organization Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis, By Key Player
  • 11.4. Competitive Scenario
    • 11.4.1. Merger & Acquisition
    • 11.4.2. Agreement, Collaboration, & Partnership
    • 11.4.3. New Product Launch & Enhancement
    • 11.4.4. Investment & Funding
    • 11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. Catalent Inc.
  • 12.2. Covance Inc.
  • 12.3. Flex
  • 12.4. IQVIA Holdings Inc.
  • 12.5. Jabil
  • 12.6. Lonza Group Ltd.
  • 12.7. Recipharm AB
  • 12.8. Sanmina Corporation
  • 12.9. Siegfried Holding AG
  • 12.10. Thermo Fisher Scientific Inc.

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET: RESEARCH PROCESS
  • FIGURE 2. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 3. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET: MARKET DYNAMICS
  • FIGURE 4. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2020 VS 2026 (%)
  • FIGURE 5. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2020 VS 2026 (USD BILLION)
  • FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2026
  • FIGURE 7. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2026 (USD BILLION)
  • FIGURE 8. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 9. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHASE I, 2018-2026 (USD BILLION)
  • FIGURE 10. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHASE I, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 11. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHASE II, 2018-2026 (USD BILLION)
  • FIGURE 12. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHASE II, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 13. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHASE III, 2018-2026 (USD BILLION)
  • FIGURE 14. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHASE III, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 15. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHASE IV, 2018-2026 (USD BILLION)
  • FIGURE 16. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHASE IV, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 17. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, 2018-2026 (USD BILLION)
  • FIGURE 18. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 19. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, 2018-2026 (USD BILLION)
  • FIGURE 20. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 21. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIOANALYSIS AND DMPK STUDIES, 2018-2026 (USD BILLION)
  • FIGURE 22. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIOANALYSIS AND DMPK STUDIES, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 23. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2026 (USD BILLION)
  • FIGURE 24. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY TOXICOLOGY TESTING, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 25. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, 2018-2026 (USD BILLION)
  • FIGURE 26. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 27. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY API/BULK DRUGS, 2018-2026 (USD BILLION)
  • FIGURE 28. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY API/BULK DRUGS, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 29. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2026 (USD BILLION)
  • FIGURE 30. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY FINISHED DOSE FORMULATIONS, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 31. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MEDICAL DEVICE, 2018-2026 (USD BILLION)
  • FIGURE 32. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MEDICAL DEVICE, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 33. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLASS I, 2018-2026 (USD BILLION)
  • FIGURE 34. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLASS I, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 35. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLASS II, 2018-2026 (USD BILLION)
  • FIGURE 36. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLASS II, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 37. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLASS III, 2018-2026 (USD BILLION)
  • FIGURE 38. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLASS III, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 39. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, 2018-2026 (USD BILLION)
  • FIGURE 40. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 41. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY ANALYTICAL SERVICES, 2018-2026 (USD BILLION)
  • FIGURE 42. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY ANALYTICAL SERVICES, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 43. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIOANALYTICAL SERVICES, 2018-2026 (USD BILLION)
  • FIGURE 44. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIOANALYTICAL SERVICES, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 45. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2020 VS 2026 (%)
  • FIGURE 46. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2020 VS 2026 (USD BILLION)
  • FIGURE 47. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2026
  • FIGURE 48. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIG PHARMACEUTICAL COMPANIES, 2018-2026 (USD BILLION)
  • FIGURE 49. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIG PHARMACEUTICAL COMPANIES, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 50. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY GENERIC PHARMACEUTICAL COMPANIES, 2018-2026 (USD BILLION)
  • FIGURE 51. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY GENERIC PHARMACEUTICAL COMPANIES, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 52. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL & MEDIUM-SIZED PHARMACEUTICAL COMPANIES, 2018-2026 (USD BILLION)
  • FIGURE 53. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL & MEDIUM-SIZED PHARMACEUTICAL COMPANIES, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 54. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 55. ARGENTINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 56. BRAZIL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 57. CANADA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 58. MEXICO HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 59. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 60. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 61. AUSTRALIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 62. CHINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 63. INDIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 64. INDONESIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 65. JAPAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 66. MALAYSIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 67. PHILIPPINES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 68. SINGAPORE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 69. SOUTH KOREA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 70. TAIWAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 71. THAILAND HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 72. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 73. FRANCE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 74. GERMANY HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 75. ITALY HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 76. NETHERLANDS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 77. QATAR HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 78. RUSSIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 79. SAUDI ARABIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 80. SOUTH AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 81. SPAIN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 82. UNITED ARAB EMIRATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 83. UNITED KINGDOM HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 84. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET: FPNV POSITIONING MATRIX
  • FIGURE 85. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET: SHARE, BY KEY PLAYER, 2020
  • FIGURE 86. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 4. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2018-2026 (USD BILLION)
  • TABLE 5. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 6. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHASE I, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 7. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHASE II, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 8. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHASE III, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 9. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHASE IV, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 10. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 11. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 12. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIOANALYSIS AND DMPK STUDIES, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 13. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY TOXICOLOGY TESTING, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 14. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 15. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY API/BULK DRUGS, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 16. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY FINISHED DOSE FORMULATIONS, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 17. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MEDICAL DEVICE, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 18. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLASS I, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 19. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLASS II, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 20. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLASS III, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 21. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LABORATORY SERVICES, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 22. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY ANALYTICAL SERVICES, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 23. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIOANALYTICAL SERVICES, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 24. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2018-2026 (USD BILLION)
  • TABLE 25. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIG PHARMACEUTICAL COMPANIES, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 26. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY GENERIC PHARMACEUTICAL COMPANIES, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 27. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL & MEDIUM-SIZED PHARMACEUTICAL COMPANIES, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 28. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 29. ARGENTINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 30. BRAZIL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 31. CANADA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 32. MEXICO HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 33. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 34. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 35. AUSTRALIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 36. CHINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 37. INDIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 38. INDONESIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 39. JAPAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 40. MALAYSIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 41. PHILIPPINES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 42. SINGAPORE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 43. SOUTH KOREA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 44. TAIWAN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 45. THAILAND HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 46. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 47. FRANCE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 48. GERMANY HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 49. ITALY HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 50. NETHERLANDS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 51. QATAR HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 52. RUSSIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 53. SAUDI ARABIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 54. SOUTH AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 55. SPAIN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 56. UNITED ARAB EMIRATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 57. UNITED KINGDOM HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 58. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET: SCORES
  • TABLE 59. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET: BUSINESS STRATEGY
  • TABLE 60. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET: PRODUCT SATISFACTION
  • TABLE 61. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET: RANKING
  • TABLE 62. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET: SHARE, BY KEY PLAYER, 2020
  • TABLE 63. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET: MERGER & ACQUISITION
  • TABLE 64. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 65. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 66. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET: INVESTMENT & FUNDING
  • TABLE 67. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 68. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET: LICENSE & PRICING